According to hormone and epidermal growth factor receptor expression status, breast cancer can be divided into several molecular subtypes: triple‐negative breast cancer (TNBC), luminal A (LA), luminal B (LB), human epidermal growth factor receptor 2 (HER2) enriched, normal‐like, and so forth. This evidence concerns the gene ERBB2 and breast carcinoma.